Skip to main content
. Author manuscript; available in PMC: 2013 Nov 24.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Feb 1;16(5):10.1016/j.bbmt.2009.12.007. doi: 10.1016/j.bbmt.2009.12.007

Figure 7.

Figure 7

Evaluation of GVL responses in LN/PP/Sp−/− following allo-BMT. Lethally irradiated, LN/PP/Sp−/− and LN/PP/Sp+/+ and wild-type C57BL/6 recipients received BMT from syngeneic or allogeneic, B10.BR donors as in Figure 3. On day 0, either 1000 (A) or 2000 (B) or 5000 (C) MBL-2 cells were added to the donor stem cell inoculum. Survival was monitored daily and the cause of each death after BMT was determined by postmortem examination and ascribed to either GVHD or leukemia as described in the Materials and Methods section. In each case, data are combined from 2 different experiments (n = 8 to 16 per group).